市場調查報告書
商品編碼
1588569
全球動態血壓計市場 - 2024-2031Global Ambulatory Blood Pressure Monitors Market - 2024-2031 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
概述
2023年,全球動態血壓監測儀市場規模達到12.0億美元,預計2031年將達到24.3億美元,2024-2031年預測期間複合年成長率為9.2%。
動態血壓監測 (ABPM) 是一種診斷方法,可在患者進行日常活動時在 24 小時內定期測量血壓。與傳統的辦公室測量相比,這種方法可以更精確地描述血壓變化,因為它記錄了白天和晚上不同時間的波動。
動態血壓監測(ABPM) 設備由一個攜帶式監測器組成,該監測器與戴在手臂或手腕上的袖帶相連,按指定的時間間隔自動充氣以捕獲血壓讀數。的一種有價值且徹底的方法。提供有關血壓變化的連續、即時資料,提高診斷精度,並使醫療保健提供者能夠做出明智的治療決策,最終在管理高血壓方面帶來更好的患者結果。
司機
高血壓盛行率上升
全球動態血壓監測儀市場的需求是由多種因素所驅動的。高血壓盛行率的增加是推動動態血壓監測(ABPM)市場的關鍵因素。由於全球有數百萬人受到影響,人口老化面臨更大的風險,因此迫切需要可靠的血壓監測解決方案。技術的進步、健康意識的提高以及政府的支持計劃進一步增加了對 ABPM 市場的需求。
高血壓是全球過早死亡的重要因素。非傳染性疾病的國際目標之一是在 2010 年至 2030 年間將高血壓盛行率資料33%。患有高血壓,其中約三分之二居住在低收入和中等收入國家。大約 46% 的成人高血壓患者不知道自己的病情,只有不到一半 (42%) 得到診斷和治療。只有 21% 的高血壓患者能夠控制住病情。
此外,該行業的主要參與者擁有技術進步和產品發布,這將推動動態血壓監測(ABPM)市場的成長。例如,2022 年 10 月,Biobeat 透過其創新的無袖帶監測技術,徹底改變了高血壓患者和醫療保健提供者的 24 小時動態血壓監測 (ABPM) 體驗。這項進步解決了與傳統血壓監測方法相關的幾個限制。
此外,2021 年 5 月,穿戴式遠端患者監測技術領域的知名品牌 Biobeat 最近推出了一款專為連續動態血壓監測 (ABPM) 而設計的新設備,該設備可以舒適地佩戴在胸部。這種先進的胸部監測設備使醫療保健專業人員能夠持續追蹤患者的血壓,從而顯著提高在傳統臨床環境之外監測生命徵象的能力。
限制
設備成本高、報銷政策有限以及與使用相關的併發症等因素預計將阻礙動態血壓監測(ABPM)市場。
Overview
The global Ambulatory blood pressure monitors market reached US$ 1.20 billion in 2023 and is expected to reach US$ 2.43 billion by 2031 growing with a CAGR of 9.2% during the forecast period 2024-2031.
Ambulatory blood pressure monitoring (ABPM) is a diagnostic method that measures a patient's blood pressure at regular intervals over 24 hours while they carry out their usual daily activities. This approach offers a more precise depiction of blood pressure variations compared to conventional office measurements, as it records fluctuations at different times throughout the day and night.
Ambulatory blood pressure monitoring (ABPM) devices consist of a portable monitor linked to a cuff worn on the arm or wrist, which automatically inflates at designated intervals to capture blood pressure readings Ambulatory blood pressure monitoring is a valuable and thorough method for assessing and managing hypertension. Delivering continuous, real-time data on blood pressure variations, improves diagnostic precision and enables healthcare providers to make well-informed treatment decisions, ultimately leading to better patient outcomes in managing hypertension.
Market Dynamics: Drivers
Rising prevalence of hypertension
The demand for the global ambulatory blood pressure monitors market is driven by multiple factors. The increasing prevalence of hypertension is a key factor propelling the ambulatory blood pressure monitoring (ABPM) market. With millions of individuals affected worldwide and an aging population at greater risk, there is an urgent demand for reliable blood pressure monitoring solutions. Advances in technology, rising health awareness, and supportive government programs further demand for the ABPM market.
Hypertension is a significant contributor to premature mortality globally. One of the international goals for noncommunicable diseases is to achieve a 33% reduction in the prevalence of hypertension between 2010 and 2030. As per WHO data in March 2023, an estimated 1.28 billion adults aged 30 to 79 years worldwide suffer from hypertension, with approximately two-thirds residing in low- and middle-income countries. About 46% of adults with hypertension are unaware of their condition, and less than half (42%) have been diagnosed and treated. Only 21% of those with hypertension manage to keep it under control.
Moreover, key players in the industry have technological advancements and product launches that would drive this ambulatory blood pressure monitoring (ABPM) market growth. For instance, in October 2022, Biobeat is revolutionizing the 24-hour ambulatory blood pressure monitoring (ABPM) experience for both hypertension patients and healthcare providers through its innovative cuffless monitoring technology. This advancement addresses several limitations associated with traditional blood pressure monitoring methods.
Also, in May 2021, Biobeat, a prominent name in wearable remote patient monitoring technologies, has recently unveiled a new device specifically designed for continuous ambulatory blood pressure monitoring (ABPM) that can be worn comfortably on the chest. This advanced chest-monitoring device allows healthcare professionals to continuously track patients' blood pressure, significantly improving the ability to monitor vital signs outside conventional clinical environments.
Restraints
Factors such as the high costs of devices, limited reimbursement policies, and complications associated with use are expected to hamper the ambulatory blood pressure monitoring (ABPM) market.
The global ambulatory blood pressure monitors market is segmented based on product type, operation type, end-user, and region.
The arm monitors segment accounted for approximately 73.2% of the global ambulatory blood pressure monitors market share
The arm monitors segment is expected to hold the largest market share over the forecast period. Arm monitors are widely regarded as more accurate than wrist monitors for measuring blood pressure. They use a standard cuff that wraps around the upper arm, which is the recommended site for obtaining reliable readings. This level of accuracy makes them the preferred option for clinicians who need precise data for diagnosis and treatment.
Additionally, arm ambulatory blood pressure monitoring (ABPM) devices have been extensively utilized in clinical settings for many years. Their established presence in hospitals and clinics lends credibility to their use among healthcare professionals, leading to a continued preference for these devices over newer wrist models. Advancements in ambulatory blood pressure monitoring (ABPM) technology have greatly changed the field of blood pressure measurement, resulting in the creation of more compact and user-friendly devices, such as wrist and arm monitors.
Moreover, key players in the industry introduce innovative products and approvals that would propel this ambulatory blood pressure monitoring (ABPM) market growth. For instance, one of the major players SunTech Medical launched the Oscar 2 ambulatory blood pressure monitor is esteemed as the leading device in 24-hour ambulatory blood pressure monitoring (ABPM).
It is designed to deliver essential diagnostic data that traditional in-clinic and home blood pressure monitors often miss, making it an invaluable resource for healthcare professionals. The device emphasizes patient comfort through its patented Orbit ABPM cuff, which is designed with a soft and flexible material that fits snugly around the arm. This design allows patients to wear the monitor for long durations without discomfort, encouraging greater compliance with monitoring protocols.
Similarly, The BPro EVO from HealthSTATS International is a third-generation ambulatory blood pressure monitor (ABPM) that integrates several advanced features aimed at improving patient monitoring and enhancing data accuracy.
Also, in October 2024, Huawei introduced the Watch D2 a smartwatch that sets itself apart with its sophisticated health monitoring features, particularly through its Ambulatory Blood Pressure Monitoring (ABPM) capability. This technology allows users to continuously monitor their blood pressure around the clock, providing critical insights into their cardiovascular health.
North America accounted for approximately 43.2% of the global ambulatory blood pressure monitors market share
North America region is expected to hold the largest market share over the forecast period. The high prevalence of hypertension in North America significantly influences the ambulatory blood pressure monitors (ABPM) market. Hypertension, commonly referred to as high blood pressure, elevates the risk of heart disease and stroke, which are among the leading causes of death in the United States.
Moreover, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, technological advancements, & investments, and product launches would propel this ambulatory blood pressure monitoring (ABPM) market growth. For instance, in August 2022, CardiAI Inc. officially launched its new 24-hour ambulatory blood pressure monitoring system, named BPAro. This device is compact and portable, manufactured in Germany, and designed for individuals to monitor their blood pressure. Utilizing Bluetooth technology, BPAro wirelessly collects data, which is then securely uploaded to a cloud database for analysis.
The major global players in the ambulatory blood pressure monitors market include Spacelabs Healthcare., BOSCH + SOHN GmbH Co. KG., SunTech Medical, Inc., Schiller AG, Baxter International Inc. (Welch Allyn, BPL Medical Technologies, A&D Company, Microlife Corporation, CONTEC MEDICAL SYSTEMS CO., LTD, and Vaso Corporation among others.
The global ambulatory blood pressure monitors market report would provide approximately 62 tables, 51 figures, and 183 pages.
LIST NOT EXHAUSTIVE